Literature DB >> 33628256

Profiling Laboratory Biomarkers Associated with COVID-19 Disease Progression: A Single-Center Experience.

Maria Khan1, Noman Shah1, Hina Mushtaq1, Valeed Jehanzeb1.   

Abstract

BACKGROUND: There is clinical importance to investigate the disease progression through potential biomarkers of SARS-CoV-2 infection. In the present study, we aim to evaluate the significance of inflammatory markers in different categories of COVID-19 in admitted patients.
METHODS: In a single-center, observational study of 50 in-hospital patients who were diagnosed with COVID-19 and admitted to the intensive care unit of a tertiary care hospital in Peshawar, infection biomarkers, including hs-CRP, serum ferritin, serum creatinine, ALT, ALP, cardiac troponin-I, and IL-6 were analyzed.
RESULTS: The median age was 61.3 years. 70% (35) were male while 30% (15) were female. We noted significantly increased hs-CRP (9.32 mg/dL ± 10.03) and ferritin levels (982.3 ng/ml ± 601.9). A noteworthy increase was observed in neutrophil count (11.05 × 109/L) and a decrease was observed in lymphocyte count (0.27 × 109/L) (P < 0.05), and the platelet count was borderline decreased (244.1 × 109/L). IL-6 levels were markedly increased in all admitted patients (100.2 pg/ml ± 122.2 pg/ml).
CONCLUSION: The serum levels of CRP, troponin-I, ALP, ALT, serum creatinine, and ferritin are markedly increased in COVID-19 patients. Increased CRP and ferritin levels were also associated with secondary bacterial infection and poor clinical outcomes.
Copyright © 2021 Maria Khan et al.

Entities:  

Year:  2021        PMID: 33628256      PMCID: PMC7879328          DOI: 10.1155/2021/6643333

Source DB:  PubMed          Journal:  Int J Microbiol


  31 in total

1.  Human alveolar macrophage and blood monocyte interleukin-6 production.

Authors:  R M Kotloff; J Little; J A Elias
Journal:  Am J Respir Cell Mol Biol       Date:  1990-11       Impact factor: 6.914

2.  Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection.

Authors:  A Lalueza; B Ayuso; E Arrieta; H Trujillo; D Folgueira; C Cueto; A Serrano; J Laureiro; C Arévalo-Cañas; C Castillo; C Díaz-Pedroche; C Lumbreras
Journal:  Clin Microbiol Infect       Date:  2020-02-28       Impact factor: 8.067

3.  [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].

Authors: 
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2020-02-10

4.  Liquid biopsy with cell free DNA: new horizons for prostate cancer.

Authors:  Giovanni Ponti; Monia Maccaferri; Antonio Percesepe; Aldo Tomasi; Tomris Ozben
Journal:  Crit Rev Clin Lab Sci       Date:  2020-08-17       Impact factor: 6.250

Review 5.  COVID-19 and Multiorgan Response.

Authors:  Sevim Zaim; Jun Heng Chong; Vissagan Sankaranarayanan; Amer Harky
Journal:  Curr Probl Cardiol       Date:  2020-04-28       Impact factor: 5.200

6.  Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience.

Authors:  Ying Sun; Yanli Dong; Lifeng Wang; Huan Xie; Baosen Li; Christopher Chang; Fu-Sheng Wang
Journal:  J Autoimmun       Date:  2020-04-24       Impact factor: 7.094

7.  Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.

Authors:  Fang Liu; Lin Li; MengDa Xu; Juan Wu; Ding Luo; YuSi Zhu; BiXi Li; XiaoYang Song; Xiang Zhou
Journal:  J Clin Virol       Date:  2020-04-14       Impact factor: 3.168

8.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

9.  Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.

Authors:  Giuseppe Lippi; Mario Plebani; Brandon Michael Henry
Journal:  Clin Chim Acta       Date:  2020-03-13       Impact factor: 3.786

10.  Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China.

Authors:  Fang Lei; Ye-Mao Liu; Feng Zhou; Juan-Juan Qin; Lihua Zhu; Peng Zhang; Xiao-Jing Zhang; Jingjing Cai; Lijin Lin; Shan Ouyang; Xiaoming Wang; Chengzhang Yang; Xu Cheng; Weifang Liu; Haomiao Li; Jing Xie; Bin Wu; Huiming Luo; Fei Xiao; Jing Chen; Liang Tao; Gang Cheng; Zhi-Gang She; Jianghua Zhou; Haitao Wang; Jun Lin; Pengcheng Luo; Shouzhi Fu; Jihui Zhou; Ping Ye; Bing Xiao; Weiming Mao; Liming Liu; Youqin Yan; Ling Liu; Guohua Chen; Hongliang Li; Xiaodong Huang; Bing-Hong Zhang; Yufeng Yuan
Journal:  Hepatology       Date:  2020-08       Impact factor: 17.298

View more
  2 in total

Review 1.  COVID-lateral damage: cardiovascular manifestations of SARS-CoV-2 infection.

Authors:  Sadeer Al-Kindi; David A Zidar
Journal:  Transl Res       Date:  2021-11-12       Impact factor: 7.012

2.  MEF: Multidimensional Examination Framework for Prioritization of COVID-19 Severe Patients and Promote Precision Medicine Based on Hybrid Multi-Criteria Decision-Making Approaches.

Authors:  Karrar Hameed Abdulkareem; Mohammed Nasser Al-Mhiqani; Ahmed M Dinar; Mazin Abed Mohammed; Mustafa Jawad Al-Imari; Alaa S Al-Waisy; Abed Saif Alghawli; Mohammed A A Al-Qaness
Journal:  Bioengineering (Basel)       Date:  2022-09-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.